Research Reports

Key takeaways

All nine director nominees elected for one-year terms with strong support ranging from 85% to 92% For votes.

Non-binding advisory vote approved executive compensation with 349.9 million For votes.

Ratification of KPMG LLP as independent auditor passed overwhelmingly with 390.5 million For votes.

Shareholder proposal for independent board chairman failed with only 72.8 million For versus 308.6 million Against.

Board determined seven executive officers including new Group Presidents Daniel Finke and Michael Carson effective May 12, 2026.

Tanya McNally continues as Chief People Officer.

Full analysis

The Annual Meeting results confirm strong shareholder support for Centene's board and governance practices, with all nine directors receiving majority approval despite varying opposition levels for some nominees. The advisory say-on-pay vote passed comfortably, signaling alignment with executive compensation structures. KPMG LLP's ratification reflects continued trust in the auditor amid routine fiscal year preparations. Rejection of the independent board chairman proposal underscores preference for the current leadership structure under CEO Sarah M. London. Concurrently, the board formalized the executive team, incorporating recent promotions of Daniel Finke and Michael Carson to key group president roles aligned with Medicaid/Marketplace and Medicare/Specialty segments, alongside continuity in other C-suite positions including Tanya McNally as Chief People Officer. These determinations provide governance stability without indicating departures.

CNC · Centene Corporation

Summary

Key takeaways

Full analysis